TAVR Medicare Fraud: Heart-Team Requirements and the Hospital Claim

TAVR Medicare fraud can involve a hospital knowingly billing for valve replacements without completing the patient evaluations Medicare requires. The missing step can be an independent examination, the physician’s documented reasoning, or making that reasoning available to the team performing the procedure. Who examined the patient, what did they conclude, and what did the procedure team have before it went ahead?

Transcatheter aortic valve replacement replaces a damaged heart valve with an artificial one. Cape Cod Hospital began offering it for patients with aortic stenosis, a condition that restricts blood flow from the heart. Its later Medicare settlement put the hospital’s patient-selection process at the center of a False Claims Act case.

Cape Cod Hospital and the TAVR Claims

Cape Cod Hospital agreed to a $24.3 million settlement over allegations that it knowingly submitted hundreds of Medicare claims for TAVR procedures that failed to meet the applicable requirements. The Justice Department’s May 16, 2024 announcement covered claims from November 2015 through December 2022.

In some instances, the government alleged, too few physicians examined a patient’s suitability for TAVR. In others, physicians failed to document and share their clinical judgment with the medical team responsible for the procedure. The hospital admitted that it failed to adhere to the applicable Medicare requirements.

The department said the conduct continued despite internal warnings. Patients lost the safeguards those evaluations were meant to provide, while Medicare paid for procedures that, the government alleged, did not meet its conditions. The hospital’s bill went through even when the required evaluation process did not.

Cape Cod also entered a five-year corporate integrity agreement with the Department of Health and Human Services’ Office of Inspector General. It provided for an independent organization to review the hospital’s paid Medicare claims annually.

A former hospital physician brought the whistleblower case. The department said the whistleblower would receive approximately $4.36 million. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

How Does Reimbursement Work for Medical Devices?

Medicare usually includes an implanted device’s cost in the payment for the procedure or hospital care. The manufacturer supplies the product, clinicians make the treatment decision, and the hospital submits its claim. That puts the hospital’s coverage obligations between the clinical decision and Medicare’s money.

The Food and Drug Administration decides whether a device may be marketed. Its authorization and a billing code do not settle Medicare coverage. Under the TAVR rules governing the Cape Cod claim period, coverage also depended on patient evaluation, hospital qualification and registry participation. Those obligations reached the health care delivered around the implant.

What Medicare Required for TAVR

The Medicare requirements behind the Cape Cod case governed how the hospital evaluated patients before TAVR. They required specified clinical personnel to examine prospective patients independently, document the rationale for their judgment and make that rationale available to the team performing the procedure.

The 2012 TAVR coverage determination governed the claims from November 2015 until the revised determination took effect June 21, 2019. The earlier version required independent face-to-face examinations by two cardiac surgeons; the later version required a cardiac surgeon and an interventional cardiologist. Both required documented clinical reasoning available to the heart team. The 2019 version governed the remainder of Cape Cod’s claim period through December 2022 and was superseded by the coverage decision effective September 10, 2026.

Independent Examination and a Shared Clinical Judgment

The evaluation had to produce a clinical judgment that the procedure team could use before performing TAVR. The physician’s reasoning was part of the required process, alongside the examination itself.

That makes separate questions of whether the examination occurred, whether the physician documented the rationale and whether the medical team had it. A physician may know why a patient was selected while the team performing the procedure has no documented explanation available. The Cape Cod allegations specifically reached that failure to document and share the judgment.

Hospital Qualifications Reached Beyond the Implanting Physician

Under the 2019 version, superseded in September 2026, a hospital without TAVR experience needed at least 50 open-heart surgeries in the previous year before starting its program. It also needed at least 20 aortic-valve-related procedures in the preceding two years and at least 300 percutaneous coronary interventions per year.

The program also needed at least two physicians with cardiac surgery privileges and at least one with interventional cardiology privileges. The qualifications reached the institution’s experience and staffing, as well as the individual patient’s care.

These conditions explain why the relevant evidence may extend outside a patient chart. We examine program activity and physician privileges when the concern is hospital qualification. A patient evaluation answers why that person was selected. The program records answer whether the hospital met the institutional conditions for Medicare coverage.

Registry Participation Was Part of Coverage

The 2019 TAVR determination, superseded in September 2026, required a prospective, national, audited registry that enrolled patients consecutively, accepted all manufactured devices and followed each patient for at least a year.

This is how Coverage with Evidence Development connects access to a procedure with evidence about its results. Medicare can condition coverage on participation in specified studies or registries. Someone working with outcomes data may know how patients entered the registry and how follow-up was recorded, a different part of the program from the physician’s examination.

How a Missing Evaluation Reaches the Medicare Claim

TAVR heart-team evaluation documentation matters to a false claims case because Medicare made the evaluation process part of coverage. The hospital’s bill is where it asks the government to pay for care delivered under those conditions.

Knowledge matters alongside the missing step. An internal warning about an evaluation requirement raises questions about who received it, what the hospital changed and what happened to the affected claims. We work through that connection with you, from the part of the program you know to the hospital’s response and billing.

Why Device Authorization Does Not Settle the Coverage Question

The Food and Drug Administration’s authorization concerns the device’s marketing. Medicare coverage can also depend on how a hospital selects patients, documents its decisions and operates its program. Those obligations reach conduct inside the institution after a manufacturer supplies the device.

The 2020 Journal of Forensic and Investigative Accounting paper A Forensic Accountant’s Guide to the Most Potent Federal Laws Used Against Healthcare Fraud explains how healthcare fraud can involve care actually delivered: a provider falsely claims to have met requirements that matter to the government’s decision to pay.

A separate national investigation of implantable cardioverter defibrillator claims announced in 2015 shows the same importance of coverage conditions in another device setting. The government alleged that hospitals implanted those devices during Medicare waiting periods after certain cardiac events or procedures. The investigation used a panel of cardiologists and reviews of thousands of patient charts. In that campaign, the coverage question concerned timing. In the Cape Cod TAVR case, it concerned the required evaluation process.

CMS issued its final revised TAVR coverage decision on September 10, 2026, effective that day. It retains heart-team care and requires a documented initial evaluation with input from cardiac surgery and interventional cardiology, plus an in-person evaluation by a heart-team TAVR operator. The evaluations must be available before the day of the procedure. It retains operator-volume requirements, hospital surgical and intensive-care capacity, and a quality-improvement process, while removing the earlier hospital-volume thresholds. For symptomatic severe aortic stenosis, it ends the coverage-with-evidence-development requirement and its mandatory registry participation. For asymptomatic severe aortic stenosis, coverage requires a CMS-approved study.

What Evidence Is Needed to Prove Fraud?

The useful evidence connects the applicable coverage condition, what the hospital actually did, who knew about the shortfall and the Medicare claim. We assess that connection with you.

An insider can explain the working process behind those records: who was expected to obtain the evaluation, how the rationale reached the procedure team and what happened when something was missing. That firsthand account helps us understand how the program operated and where the required process broke down.

When You Know the Heart-Team Process Broke Down

If you know a TAVR program billed Medicare despite missing required evaluations or clinical documentation, speak with our whistleblower experts about the heart-team process and the claims. We bring in Medicare fraud whistleblower lawyers who understand hospital coverage cases and stay beside you through the case. Put your firsthand knowledge of the clinical decisions, internal warnings and billing to work with us to build your strongest TAVR whistleblower case.